• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

The New VDM

  • Wed, 1/6/10 - 12:41pm
  • 0 Comments
  • 1963 reads
Author(s): 

Frank J. Criado
Editor-in-Chief

Vascular Surgery and Endovascular Intervention; Union Memorial Hospital/MedStar Health,
Baltimore, Maryland
frank.criado@medstar.net

pg. A1

______________________

At the dawn of a new decade, it is with pleasure and a sense of excitement that I write the first Corner editorial of 2010 to introduce a new format for Vascular Disease Management as it becomes an online-only publication. We are confident this will enhance the journal’s relevance and reach in a most significant way. The most salient advantages of such evolution can be listed as follows:

• The number of issues will double (beginning immediately) from 6 to 12 per year, making it a monthly journal;

• A much-increased capacity to expand content, including a larger number of original papers;

• A shortened time lapse from manuscript submission to publication;

• A full menu of scientific, clinical, technological, and informational sections to address some of the most relevant issues for all vascular specialists. These will include:

- Basic and clinical research, case reports, and clinical reviews of relevant topics;

- New techniques and devices;
- Editorial commentaries and position statements;
- Newswire featuring clinical, regulatory, and industry news;
- Events calendar and useful links;
- Monthly blogs by noted key opinion leaders, interviews, and more.

The new VDM will obviously have a much broader scope and coverage, but it will do so while retaining the fundamental pillars of the double-blind peer-review process, and indexing on Embase and Scopus. I think the most attractive features of the online-only format derive from the virtual elimination of the considerable costs associated with printing and distribution allowing (in turn) the dramatic expansion of content (as described above), and effective internet-based worldwide exposure for authors and their papers.

So, it’s good news all around! But these plans and efforts can only reach their full potential as a result of interaction with an engaged audience. More than ever before, we absolutely need to hear from you — the VDM reader and follower: tell us what works and what doesn’t. And tell us whether your needs are being addressed or not. We will do our utmost to fulfill the mission and make VDM an ever-growing source for today’s vascular specialists. That’s a promise.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications